This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Erratum

The May 2005 article "Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis" by K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger (Endocrine Reviews 26:423–438, 2005) contained the following errors:

On page 425, the second sentence in the paragraph subtitled "A. SPRM definition" should read as follows: Accordingly, SPRMs represent a class of PR ligands that exerts clinically relevant tissue-selective progesterone agonist, antagonist, partial, or mixed agonist/antagonist effects on various progesterone target tissues in an in vivo situation depending on the biological action studied.

On page 425, in the Leiomyoma row in Table 1, the downward arrow in the Progestins column should be removed and placed in the SPRM column. The corrected table appears below.

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content